SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...

Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...

Tandem Diabetes Care announced plans to link its automated insulin delivery systems with an upcoming wearable monitor from Abbott that aims to measure glucose as well as ketone levels. The dual sensor ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...

Tandem Diabetes Care, Inc. ( NASDAQ: TNDM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 9:15 AM EDT ...

Analysts have set 12-month price targets for Tandem Diabetes Care, revealing an average target of $19.78, a high estimate of ...